Gather remaining data for manuscript submission as well as screening of drug compounds to ameliorate NGLY1 mediated disfunction. (phase II); period of performance: july 27, 2020 - march 26, 2021
Ended Purchase Order Awarded
- Contract number
- 75N95020P00349
- Awardee
-
Hesperos, Inc. UEI R1LSLA5YJMJ9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $159,282
Award facts
- Opportunity
-
- Gathering remaining data for manuscript submission as well as screening of drug compounds to ameliorate NGLY1 mediated disfunction. (Phase II) Solicitation · 75N95020Q00191 · Posted Jul 13, 2020
- Contract value 100% obligated
- $159,282.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Orlando, FL 32826, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award to Hesperos, Inc. is for $159,282 to gather remaining data for manuscript submission and screen drug compounds to ameliorate NGLY1 dysfunction (Phase II). The contract is with the National Institutes of Health's (NIH) National Center for Advancing Translational Sciences (NCATS) and does not have a set-aside designation. Hesperos, Inc. is a leading company in organ-on-a-chip technology that provides a platform for accurate drug testing and efficacy prediction. Through this contract, Hesperos will leverage its technology to support NCATS' research into rare diseases. The contract has a period of performance from July 27, 2020 to March 26, 2021.
Quick answers
Who was awarded contract 75N95020P00349?
75N95020P00349 was awarded to Hesperos, Inc. by National Institute on Drug Abuse (National Institutes of Health) on July 22, 2020.
How much is contract 75N95020P00349 worth?
The government has obligated $159,282 on 75N95020P00349.
Which agency awarded contract 75N95020P00349?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020P00349, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95020P00349 competed?
The extent of competition for 75N95020P00349 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award